Axial partners with great founders and inventors. We invest in early-stage life sciences companies such as Appia Bio, Seranova Bio, Delix Therapeutics, Simcha Therapeutics, among others often when they are no more than an idea. We are fanatical about helping the rare inventor who is compelled to build their own enduring business. If you or someone you know has a great idea or company in life sciences, Axial would be excited to get to know you and possibly invest in your vision and company . We are excited to be in business with you - email us at firstname.lastname@example.org
A great way to find compelling startup ideas is to ask: What do other companies enable? Technology both solves and creates problems. Case studies are powerful tools to uncover these opportunities.
F-Star Therapeutics arguably has the best bispecific design platform in the world. Founded in 2006, F-Star’s platform is based on Florian Rüker’s work out of Austria. The platform is focused on combinatorially engineering Fc regions to develop antibodies with new binding capabilities and invent bispecifics with manufacturability similar to monoclonal antibodies. This technology helped F-Star raise around $200M in non-dilutive capital building one of the best bispecific engineering platforms in the world.